GlassScriptPhysician profile
Kathryn M Roberts
NPI 1295294445
$1,419.64
in general payments reported to CMS, 2019-2025
11 companies · $820 in 2025
The $820 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.27 · 2022: $125 · 2023: $127 · 2024: $297 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $599.04 | 2021-2025 | Yeztugo, Biktarvy, Descovy |
| Viiv Healthcare Company | $459.31 | 2024-2025 | Apretude, Cabenuva, Dovato |
| Antares Pharma, INC. | $76.06 | 2025 | Xyosted |
| Abbvie INC. | $69.73 | 2023-2025 | Mavyret |
| Exact Sciences Corporation | $60.49 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $45.36 | 2023-2024 | |
| Theratechnologies INC. | $24.01 | 2024 | Trogarzo, Egrifta |
| Xeris Pharmaceuticals, INC. | $22.58 | 2023 | Gvoke Hypopen |
| Tolmar, INC. | $22.18 | 2025 | Jatenzo |
| Novo Nordisk INC | $21.85 | 2025 | Wegovy |
| Sanofi Pasteur INC. | $19.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.